U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
188401188401S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AMLCompletedHas ResultsLeukemiaDrug: gemtuzumab ozogamicin|Other: observation|Drug: Cytosine arabinoside|Drug: Daunomycinhttps://ClinicalTrials.gov/show/NCT00085709
188402188402VELCADE® (Bortezomib) With Rituximab in Subjects With Relapsed or Refractory Indolent B-Cell LymphomaCompletedNo Results AvailableB-Cell Lymphoma|Follicular Lymphoma|Marginal LymphomaDrug: VELCADE and rituximabhttps://ClinicalTrials.gov/show/NCT00085696
188403188403Herpes Virus-6 and EpilepsyCompletedNo Results AvailableEpilepsyhttps://ClinicalTrials.gov/show/NCT00085683
188404188404Cytokine Gene Polymorphisms in Bone Marrow FailureCompletedNo Results AvailableBone Marrow Diseaseshttps://ClinicalTrials.gov/show/NCT00085670
188405188405Brain Electrical Stimulation to Enhance Recovery After StrokeCompletedNo Results AvailableStrokehttps://ClinicalTrials.gov/show/NCT00085657
188406188406Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing SpondylitisCompletedHas ResultsAnkylosing SpondylitisBiological: adalimumab (D2E7)|Biological: placebohttps://ClinicalTrials.gov/show/NCT00085644
188407188407Cisplatin and Radiation Therapy With or Without Hyperthermia Therapy in Treating Patients With Cervical CancerTerminatedHas ResultsCervical CancerDrug: cisplatin|Procedure: hyperthermia treatment|Radiation: brachytherapy|Radiation: external beam radiation therapyhttps://ClinicalTrials.gov/show/NCT00085631
188408188408Interleukin-2 and Sargramostim After Chemotherapy in Treating Patients With Stage III or Stage IV MelanomaWithdrawnNo Results AvailableMelanoma (Skin)Biological: aldesleukin|Biological: sargramostim|Procedure: adjuvant therapyhttps://ClinicalTrials.gov/show/NCT00085579
188409188409Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate CancerCompletedNo Results AvailableBrain and Central Nervous System Tumors|Prostate CancerDrug: everolimus|Drug: gefitinibhttps://ClinicalTrials.gov/show/NCT00085566
188410188410Tipifarnib and Erlotinib Hydrochloride in Treating Patients With Advanced Solid TumorsActive, not recruitingNo Results AvailableAdult Solid NeoplasmDrug: Erlotinib Hydrochloride|Other: Laboratory Biomarker Analysis|Other: Pharmacological Study|Drug: Tipifarnibhttps://ClinicalTrials.gov/show/NCT00085553
188411188411FR901228 in Treating Patients With Recurrent High-Grade GliomasCompletedNo Results AvailableAdult Anaplastic Astrocytoma|Adult Anaplastic Oligodendroglioma|Adult Giant Cell Glioblastoma|Adult Gliosarcoma|Adult Mixed Glioma|Recurrent Adult Brain TumorDrug: romidepsinhttps://ClinicalTrials.gov/show/NCT00085540
188412188412FR901228 in Treating Patients With Relapsed or Refractory Advanced Ovarian Epithelial CancerWithdrawnNo Results AvailableOvarian CancerDrug: depsipeptidehttps://ClinicalTrials.gov/show/NCT00085527
188413188413S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNo Results AvailableLung CancerDrug: cetuximab|Drug: carboplatin|Drug: paclitaxelhttps://ClinicalTrials.gov/show/NCT00085501
188414188414Vaccine Therapy in Treating Patients With Stage III or Stage IV MelanomaCompletedNo Results AvailableMelanoma (Skin)Biological: autologous tumor cell vaccine|Biological: therapeutic autologous dendritic cellshttps://ClinicalTrials.gov/show/NCT00085488
188415188415Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell FibroblastomaCompletedNo Results AvailableSarcomaDrug: imatinib mesylate|Procedure: conventional surgeryhttps://ClinicalTrials.gov/show/NCT00085475
188416188416Gene-Modified White Blood Cells Followed By Interleukin-2 and Vaccine Therapy in Treating Patients With Metastatic MelanomaCompletedNo Results AvailableMelanoma (Skin)Biological: aldesleukin|Biological: filgrastim|Biological: gp100-fowlpox vaccine|Biological: therapeutic autologous lymphocytes|Biological: therapeutic tumor infiltrating lymphocytes|Drug: cyclophosphamide|Drug: fludarabine phosphatehttps://ClinicalTrials.gov/show/NCT00085462
188417188417Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic CancerCompletedNo Results AvailableLeukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative NeoplasmsBiological: alemtuzumab|Drug: cyclosporine|Drug: fludarabine phosphate|Drug: melphalan|Drug: mycophenolate mofetil|Procedure: peripheral blood stem cell transplantation|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00085449
188418188418DC Vaccine Combined With IL-2 and IFNα-2a in Treating Patients With mRCCCompletedHas ResultsKidney CancerBiological: Aldesleukin,|Biological: autologous tumor cell vaccine|Biological: recombinant interferon alfahttps://ClinicalTrials.gov/show/NCT00085436
188419188419Cyclophosphamide, Fludarabine, and High-Dose Interleukin-2 in Treating Patients With Metastatic MelanomaCompletedHas ResultsMelanoma (Skin)Biological: aldesleukin|Biological: sargramostim|Drug: cyclophosphamide|Drug: fludarabine phosphatehttps://ClinicalTrials.gov/show/NCT00085423
188420188420Bortezomib in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Duct or GallbladderCompletedNo Results AvailableAdenocarcinoma of the Extrahepatic Bile Duct|Adenocarcinoma of the Gallbladder|Advanced Adult Primary Liver Cancer|Gastrointestinal Cancer|Localized Unresectable Adult Primary Liver Cancer|Recurrent Adult Primary Liver Cancer|Recurrent Extrahepatic Bile DDrug: bortezomibhttps://ClinicalTrials.gov/show/NCT00085410
188421188421Vaccine Therapy in Treating Patients With Stage III or Stage IV MelanomaRecruitingNo Results AvailableMelanoma (Skin)Biological: autologous dendritic cell-tumor fusion vaccine|Biological: gp100 antigen|Biological: therapeutic autologous dendritic cellshttps://ClinicalTrials.gov/show/NCT00085397
188422188422PEG-Interferon Alfa-2b in Treating Patients With Platinum-Resistant Ovarian Epithelial, Peritoneal, or Fallopian Tube CancerTerminatedNo Results AvailableFallopian Tube Cancer|Ovarian Cancer|Peritoneal Cavity CancerBiological: PEG-interferon alfa-2b|Drug: PEG-interferon alfa-2b|Biological: PEG-interferon alfa-2bhttps://ClinicalTrials.gov/show/NCT00085384
188423188423Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the PancreasCompletedNo Results AvailableAcinar Cell Adenocarcinoma of the Pancreas|Duct Cell Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage III Pancreatic Cancer|Stage IV Pancreatic CancerDrug: triapinehttps://ClinicalTrials.gov/show/NCT00085371
188424188424Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)CompletedNo Results AvailableBrenner Tumor|Fallopian Tube Cancer|Ovarian Carcinosarcoma|Ovarian Clear Cell Cystadenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mixed Epithelial Carcinoma|Ovarian Mucinous Cystadenocarcinoma|Ovarian Serous Cystadenocarcinoma|Ovarian UndiffereDrug: carboplatin|Drug: paclitaxel|Drug: docetaxel|Biological: bevacizumabhttps://ClinicalTrials.gov/show/NCT00085358
188425188425Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple MyelomaWithdrawnNo Results AvailableStage II Multiple Myeloma|Stage III Multiple Myeloma|Refractory Plasma Cell NeoplasmDrug: arsenic trioxide|Drug: ascorbic acid|Drug: melphalan|Procedure: chemosensitization/potentiation|Procedure: chemotherapyhttps://ClinicalTrials.gov/show/NCT00085345
188426188426Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)CompletedNo Results AvailableEndometrial CancerDrug: docetaxelhttps://ClinicalTrials.gov/show/NCT00085332
188427188427Interferon Beta in Treating Patients With Metastatic Cutaneous Melanoma or Ocular MelanomaCompletedNo Results AvailableStage IV Melanoma|Recurrent MelanomaBiological: recombinant interferon betahttps://ClinicalTrials.gov/show/NCT00085306
188428188428Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131CompletedHas ResultsRecurrent Thyroid Cancer|Stage IVA Follicular Thyroid Cancer|Stage IVA Papillary Thyroid Cancer|Stage IVB Follicular Thyroid Cancer|Stage IVB Papillary Thyroid Cancer|Stage IVC Follicular Thyroid Cancer|Stage IVC Papillary Thyroid CancerDrug: Decitabine|Radiation: Iodine I 131|Biological: Recombinant thyrotropin alfa|Radiation: Fludeoxyglucose F 18|Procedure: Positron emission tomographyhttps://ClinicalTrials.gov/show/NCT00085293
188429188429Erlotinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerCompletedNo Results AvailableRecurrent Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung CancerDrug: erlotinib hydrochloride|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00085280
188430188430Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeActive, not recruitingNo Results AvailableAdult Giant Cell Glioblastoma|Adult Glioblastoma|Adult GliosarcomaDrug: cilengitide|Drug: temozolomide|Radiation: radiation therapy|Other: laboratory biomarker analysis|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT00085254

* Görseller ve İçerik tekif hakkına sahip olabilir